Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Molecular Oncology|November 8, 2021
RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venuesAlexander Scheiter, Katja Evert, Lucas Reibenspies, et al.Oncotarget|December 7, 2017
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesisAntonio Cigliano, Maria G Pilo, Lei Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic CholangiocarcinomaXinhua Song, Xianqiong Liu, Haichuan Wang, et al.Molecular & Cellular Proteomics : MCP|July 23, 2025
Accurate MS-Based Diagnostic Amyloid Typing Using Endogenously Normalized Protein Intensities in Formalin-Fixed Paraffin-Embedded TissueVanessa Hollfoth, Arslan Ali, Eyyub Bag, et al.Journal of Experimental & Clinical Cancer Research : CR|June 2, 2022
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human diseaseAntonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.Gastroenterology|February 20, 2013
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinomaDarjus Felix Tschaharganeh, Xin Chen, Philipp Latzko, et al.Gastroenterology|May 24, 2016
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer CellsEngin Gürlevik, Bettina Fleischmann-Mundt, Jennifer Brooks, et al.Hepatology (Baltimore, Md.)|April 4, 2017
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesisPin Liu, Mengmeng Ge, Junjie Hu, et al.Gut|April 8, 2019
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humansLi Che, Wenna Chi, Yu Qiao, et al.Journal of Hepatology|July 23, 2017
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in miceShanshan Zhang, Xinhua Song, Dan Cao, et al.Pageof 12